199 related articles for article (PubMed ID: 35294598)
1. Inter-individual variation in chlorpyrifos toxicokinetics characterized by physiologically based kinetic (PBK) and Monte Carlo simulation comparing human liver microsome and Supersome
Zhao S; Wesseling S; Rietjens IMCM; Strikwold M
Arch Toxicol; 2022 May; 96(5):1387-1409. PubMed ID: 35294598
[TBL] [Abstract][Full Text] [Related]
2. Integrating physiologically based kinetic (PBK) and Monte Carlo modelling to predict inter-individual and inter-ethnic variation in bioactivation and liver toxicity of lasiocarpine.
Ning J; Rietjens IMCM; Strikwold M
Arch Toxicol; 2019 Oct; 93(10):2943-2960. PubMed ID: 31511935
[TBL] [Abstract][Full Text] [Related]
3. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon.
Zhao S; Wesseling S; Spenkelink B; Rietjens IMCM
Arch Toxicol; 2021 May; 95(5):1573-1593. PubMed ID: 33715020
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.
Al-Subeihi AA; Alhusainy W; Kiwamoto R; Spenkelink B; van Bladeren PJ; Rietjens IM; Punt A
Toxicol Appl Pharmacol; 2015 Mar; 283(2):117-26. PubMed ID: 25549870
[TBL] [Abstract][Full Text] [Related]
6. In vitro-in silico-based prediction of inter-individual and inter-ethnic variations in the dose-dependent cardiotoxicity of R- and S-methadone in humans.
Shi M; Dong Y; Bouwmeester H; Rietjens IMCM; Strikwold M
Arch Toxicol; 2022 Aug; 96(8):2361-2380. PubMed ID: 35604418
[TBL] [Abstract][Full Text] [Related]
7. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
Omwenga I; Zhao S; Kanja L; Mol H; Rietjens IMCM; Louisse J
Arch Toxicol; 2021 Apr; 95(4):1287-1301. PubMed ID: 33651127
[TBL] [Abstract][Full Text] [Related]
8. Physiologically Based Kinetic Modeling-Facilitated Reverse Dosimetry to Predict In Vivo Red Blood Cell Acetylcholinesterase Inhibition Following Exposure to Chlorpyrifos in the Caucasian and Chinese Population.
Zhao S; Kamelia L; Boonpawa R; Wesseling S; Spenkelink B; Rietjens IMCM
Toxicol Sci; 2019 Sep; 171(1):69-83. PubMed ID: 31214721
[TBL] [Abstract][Full Text] [Related]
9. Use of a probabilistic PBPK/PD model to calculate Data Derived Extrapolation Factors for chlorpyrifos.
Poet TS; Timchalk C; Bartels MJ; Smith JN; McDougal R; Juberg DR; Price PS
Regul Toxicol Pharmacol; 2017 Jun; 86():59-73. PubMed ID: 28238854
[TBL] [Abstract][Full Text] [Related]
10. A physiologically based kinetic modeling of ethyl tert-butyl ether in humans-An illustrative application of quantitative structure-property relationship and Monte Carlo simulation.
Watanabe-Matsumoto S; Yoshida K; Meiseki Y; Ishida S; Hirose A; Yamada T
J Toxicol Sci; 2022; 47(2):77-87. PubMed ID: 35110473
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion.
Foxenberg RJ; Ellison CA; Knaak JB; Ma C; Olson JR
Toxicology; 2011 Jul; 285(1-2):57-66. PubMed ID: 21514354
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of human interindividual variation in bioactivation of estragole using physiologically based biokinetic modeling.
Punt A; Jeurissen SM; Boersma MG; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2010 Feb; 113(2):337-48. PubMed ID: 19920071
[TBL] [Abstract][Full Text] [Related]
13. Phosmet bioactivation by isoform-specific cytochrome P450s in human hepatic and gut samples and metabolic interaction with chlorpyrifos.
Santori N; Buratti FM; Dorne JCM; Testai E
Food Chem Toxicol; 2020 Sep; 143():111514. PubMed ID: 32590074
[TBL] [Abstract][Full Text] [Related]
14. CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes.
Buratti FM; Volpe MT; Meneguz A; Vittozzi L; Testai E
Toxicol Appl Pharmacol; 2003 Feb; 186(3):143-54. PubMed ID: 12620367
[TBL] [Abstract][Full Text] [Related]
15. Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat.
Timchalk C; Poet TS
Neurotoxicology; 2008 May; 29(3):428-43. PubMed ID: 18394709
[TBL] [Abstract][Full Text] [Related]
16. Effects of chlorpyrifos on the transcription of CYP3A cDNA, activity of acetylcholinesterase, and oxidative stress response of goldfish (Carassius auratus).
Ma J; Liu Y; Niu D; Li X
Environ Toxicol; 2015 Apr; 30(4):422-9. PubMed ID: 24190793
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the bioactivation and detoxification of diazinon and chlorpyrifos, and the inhibition of acetylcholinesterase activity in Chirostoma jordani from three lakes with low to high organophosphate pesticides contamination.
Dzul-Caamal R; Domínguez-Lòpez ML; Olivares-Rubio HF; García-Latorre E; Vega-López A
Ecotoxicology; 2014 Jul; 23(5):779-90. PubMed ID: 24573775
[TBL] [Abstract][Full Text] [Related]
18. Foetal and neonatal exposure to chlorpyrifos: biochemical and metabolic alterations in the mouse liver at different developmental stages.
Buratti FM; De Angelis G; Ricceri L; Venerosi A; Calamandrei G; Testai E
Toxicology; 2011 Feb; 280(3):98-108. PubMed ID: 21129432
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome P450s (CYP).
Sams C; Cocker J; Lennard MS
Xenobiotica; 2004 Oct; 34(10):861-73. PubMed ID: 15764407
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the human liver microsomal and human cytochrome P450 1A2 and 3A4 metabolism of estradiol by deployment-related and other chemicals.
Usmani KA; Cho TM; Rose RL; Hodgson E
Drug Metab Dispos; 2006 Sep; 34(9):1606-14. PubMed ID: 16790556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
